Blog
Posted November 19, 2010 in Cosmetic Surgery
A study published in the Journal of Clinical and Aesthetic Dermatology surveyed more than 300 patients to find out more about who makes up the ‘average’ population of cosmetic surgery seekers. According to survey results, the average patients having cosmetic treatments are college-educated, working moms. These results are unsurprising and coincide with statistical data released by […]
Read More
Posted November 12, 2010 in Plastic Surgery In The Media
The same drug that has helped countless Eugene Latisse users grow long, luscious lashes, is reportedly being used in a new hair loss treatment product developed by Allergan that is set to begin FDA trials this month. According to hair restoration specialist Dr. Alan Bauman, Latisse, which contains only a small amount of the active […]
Read More
Posted November 04, 2010 in Injection Treatments
When most people meet for the first time, they consciously or subconsciously make quick judgments based on a person’s physical appearance to determine their first impression. Eugene plastic surgeon Dr. Lee Daniel is acutely aware of this human tendency and often meets patients who seek cosmetic treatment to not only feel better about themselves, but […]
Read More
Posted October 30, 2010 in Plastic Surgery In The Media
Canada’s biggest drug maker Apotex was recently sued by U.S. pharmaceutical giant Allergan after the Canadian company, which specializes in generic pharmaceuticals, filed an application with the FDA to make and sell a generic version of Latisse eyelash enhancer. Allergan filed the lawsuit in the U.S. District Court for the Middle District of North Carolina, […]
Read More
Posted October 21, 2010 in Plastic Surgery
Although a controversial topic among plastic surgeons due to its inconsistent results, breast augmentation via fat injection may soon be a viable option for patients who wish to enlarge or rebuild their breasts, thanks to promising new technology. Cytori Therapeutics recently developed new technology that may finally make natural breast augmentation with fat grafting a […]
Read More
Posted October 06, 2010 in Plastic Surgery
Eugene plastic surgeon Dr. Lee Daniel explored new techniques in upper eyelid rejuvenation using autologous fat injections alongside hundreds of surgeons from all over North America at the 2010 American Society of Plastic Surgeons meeting. Recent research conducted by Dr. Patrick Sullivan revealed that fat injections have proven safe and effective for restoring volume to […]
Read More
Posted September 30, 2010 in Medical Spa
The harms of sun overexposure have been clearly documented over the years, but millions of Americans still choose to sunbathe or visit the tanning salon in search of that widely coveted bronze complexion. Although physicians have long urged patients to limit sun exposure and protect against damaging UV rays, health messages rarely take precedence over […]
Read More
Posted September 06, 2010 in Injection Treatments
Medicis, pharmaceutical giant and makers of the popular wrinkle filler Restylane, launched a rebate promotion in March 2010 to promote its injectable wrinkle relaxer and Botox competitor Dysport. To date, more than 100,000 patients have taken the so-called “Dysport Challenge.” The Dysport Challenge promotion essentially rewards patients who report whether they were satisfied with their Dysport […]
Read More
Posted August 12, 2010 in Plastic Surgery
Statistics recently released by the International Society of Aesthetic Plastic Surgery offer insight into global plastic surgery trends, suggesting that despite economic troubles, consumer demand for body contouring and facial plastic surgery procedures, as well as injectable treatments, remained high in 2009. The ISAPS organization sent surveys to more than 30,000 plastic surgeons in 25 […]
Read More
Posted August 06, 2010 in Injection Treatments
Xeomin, a botulinum type A injectable treatment made by German pharmaceutical giant Merz, was finally FDA-approved to join Botox and Dysport on the U.S. market in late September, after having been available in Europe since 2008. Xeomin will likely compete with Botox and Dysport for a share of patients seeking to reduce forehead creases and […]
Read More
